TAMERA PACE: Open Payments
NPI 1427045897 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,238 in 115 payments from 22 companies in 2025. Trend: 2023 $3,463 · 2024 $2,886 · 2025 $2,238
Food & beverage: $2,238
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $455 |
| PFIZER INC. | 21 | $345 |
| AstraZeneca Pharmaceuticals LP | 12 | $238 |
| ABBVIE INC. | 12 | $203 |
| Lilly USA, LLC | 6 | $126 |
| Astellas Pharma US Inc | 4 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $103 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| GlaxoSmithKline, LLC. | 5 | $87 |
Products named: Ozempic, NURTEC ODT, FARXIGA, Wegovy, UBRELVY, Veozah, MOUNJARO, CAPLYTA.
Industry payments across TN — which companies pay providers there.
